首页> 美国卫生研究院文献>other >Structure-Based Design of a T Cell Receptor Leads to Nearly 100-Fold Improvement in Binding Affinity for pepMHC
【2h】

Structure-Based Design of a T Cell Receptor Leads to Nearly 100-Fold Improvement in Binding Affinity for pepMHC

机译:T细胞受体的基于结构的设计导致pepMHC结合亲和力提高近100倍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T cell receptors (TCRs) are proteins that recognize peptides from foreign proteins bound to the Major Histocompatibility Complex (MHC) on the surface of an antigen-presenting cell. This interaction enables the T cells to initiate a cell-mediated immune response to terminate cells displaying the foreign peptide on their MHC. Naturally occurring TCRs have high specificity but low affinity toward the peptide-MHC (pepMHC) complex. This prevents the usage of solubilized TCRs for diagnosis and treatment of viral infections or cancers. Efforts to enhance the binding affinity of several TCRs have been reported in recent years, through randomized libraries and in vitro selection. However, there have been no reported efforts to enhance the affinity via structure-based design, which allows more control and understanding of the mechanism of improvement. Here we have applied structure-based design to a human TCR to improve its pepMHC binding. Our design method evolved based on iterative steps of prediction, testing and generating more predictions based on the new data. The final design function, named ZAFFI, has a correlation of 0.77 and average error of 0.35 kcal/mol with the binding free energies of 26 point mutations for this system that we measured by surface plasmon resonance. Applying the filter we developed to remove non-binding predictions, this correlation increases to 0.85 and the average error decreases to 0.3 kcal/mol. Using this algorithm, we predicted and tested several point mutations that improved binding, with one giving over 6-fold binding improvement. Four of the point mutations that improved binding were then combined to give a mutant TCR that binds the pepMHC 99 times more strongly than the wild-type TCR.
机译:T细胞受体(TCR)是一种蛋白质,可以识别与抗原呈递细胞表面上的主要组织相容性复合物(MHC)结合的外来蛋白质中的肽。这种相互作用使T细胞能够启动细胞介导的免疫反应,从而终止在其MHC上展示外源肽的细胞。天然存在的TCR具有高特异性,但对肽-MHC(pepMHC)复合物的亲和力低。这阻止了将溶解的TCR用于诊断和治疗病毒感染或癌症。近年来,已经报道了通过随机文库和体外选择来增强几种TCR的结合亲和力的努力。但是,尚未有报告通过基于结构的设计来增强亲和力,这使得可以更好地控制和理解改进机制。在这里,我们将基于结构的设计应用于人类TCR,以改善其pepMHC结合。我们的设计方法是根据预测,测试和基于新数据生成更多预测的迭代步骤发展而来的。最终的设计函数ZAFFI与我们通过表面等离振子共振测量的该系统的26个点突变的结合自由能具有0.77的相关性和0.35 kcal / mol的平均误差。应用我们开发的过滤器以消除非约束性预测,该相关性增加到0.85,平均误差减少到0.3 kcal / mol。使用这种算法,我们预测并测试了几个点突变,这些点突变改善了结合,其中一个结合突变提高了6倍。然后将结合改善的点突变中的四个结合在一起,得到突变的TCR,其结合pepMHC的强度是野生型TCR的99倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号